GLOBE LIFE INC. (GL) Form 8-K — Oct 21, 2026
Globe Life (NYSE: GL) reported Q3 2026 net income of $4.62 per diluted share versus $4.73 a year ago, with net operating income of $4.84 versus $4.81. Total premium revenue grew 7% to $1.31 billion, and book value per share rose 23% to $85.35. The company cut full-year 2026 EPS guidance to $15.35-$15.65, attributing the adjustment to two items at its United American division — roughly $16 million of high-severity claims at its Evry group health business and about $7 million of excess Medicare Supplement claims from a CMS claims processing delay — rather than a change in its core business.
Key figures
- Eps
- 4.62
- Revenue
- 1595937000
- Guidance
- FY2026 net operating EPS lowered to $15.35-$15.65; FY2027 net operating EPS estimated at $16.10-$17.10 (+7.1% at midpoint); FY2026 buyback raised to $725M-$775M from $670M-$700M
- Net Income
- 361107000
- Revenue Yoy
- 5.5%
- Shares Outstanding
- 78225000
- Evry loss q3
- approximately $16 million
- Buyback cost q3
- 185000000
- Buyback avg price
- 175.61
- Buyback shares q3
- 1.1 million
- Net income roe 9m
- 19.7%
- Net operating eps
- 4.84
- Premium growth pct
- 7
- Book value per share
- 85.35
- Net operating income
- 378838000
- Total premium revenue
- 1311409000
- Cms delay excess claims
- approximately $7 million
- Life underwriting income
- 481832000
- Net operating eps yoy pct
- 1
- Book value per share ex aoci
- 103.62
- Remeasurement gain before tax
- 120500000
- Investment portfolio book value
- 19633378000
- Life underwriting income chg pct
- -4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.